Skip to search formSkip to main contentSkip to account menu

Helixate

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Anti-drug antibodies to coagulation factor VIII (fVIII), often termed inhibitors, present the greatest economical and treatment… 
2018
2018
Essentials Factor VIII inhibitors are the most serious complication in patients with hemophilia A. Aggregates in… 
2014
2014
taken as reference in RODIN gave, in the frame of a recent prospective study (EPIC), a relatively high incidence of inhibitors… 
2014
2014
The administration of therapeutic factor VIII (FVIII) to treat or prevent haemorrhages in haemophilia A patients results, in up… 
Review
2001
Review
2001
  • B. Boedeker
  • Seminars in Thrombosis and Hemostasis
  • 2001
  • Corpus ID: 34046392
The state-of-the-art treatment for hemophilia A is replacement therapy with recombinant factor VIII (rFVIII) made possible by… 
1998
1998
Recombinant hirudin (rH) is a highly specific thrombin inhibitor which is under clinical investigation for various thrombotic…